Intestinal diverticula are more likely to develop in individuals with a low fibre diet. This patient’s diet appears to be lacking in fruits and vegetables, which increases their risk. While smoking has been linked to diverticulosis, there is no evidence to suggest that alcohol consumption is a risk factor. Although obesity is associated with an increased risk, this patient’s BMI is not in the obese range. Diverticulosis is more prevalent in men than women, and abdominal surgery is not a known risk factor.

Diverticulosis is a common condition where multiple outpouchings occur in the bowel wall, typically in the sigmoid colon. It is more accurate to use the term diverticulosis when referring to the presence of diverticula, while diverticular disease is reserved for symptomatic patients. Risk factors for this condition include a low-fibre diet and increasing age. Symptoms of diverticulosis can include altered bowel habits and colicky left-sided abdominal pain. A high-fibre diet is often recommended to alleviate these symptoms.

Diverticulitis is a complication of diverticulosis where one of the diverticula becomes infected. The typical presentation includes left iliac fossa pain and tenderness, anorexia, nausea, vomiting, diarrhea, and signs of infection such as pyrexia, raised WBC, and CRP. Mild attacks can be treated with oral antibiotics, while more severe episodes require hospitalization. Treatment involves nil by mouth, intravenous fluids, and intravenous antibiotics such as a cephalosporin and metronidazole. Complications of diverticulitis include abscess formation, peritonitis, obstruction, and perforation.

The biliary tree is composed of various ducts, including the cystic duct that transports bile from the gallbladder. The right and left hepatic ducts in the liver merge to form the common hepatic duct, which then combines with the cystic duct to create the common bile duct. The pancreatic duct from the pancreas also connects to the common bile duct, and they both empty into the duodenum through the hepatopancreatic ampulla (of Vater). The accessory duct, which may or may not exist, is a small supplementary duct(s) to the biliary tree.

The gallbladder is a sac made of fibromuscular tissue that can hold up to 50 ml of fluid. Its lining is made up of columnar epithelium. The gallbladder is located in close proximity to various organs, including the liver, transverse colon, and the first part of the duodenum. It is covered by peritoneum and is situated between the right lobe and quadrate lobe of the liver. The gallbladder receives its arterial supply from the cystic artery, which is a branch of the right hepatic artery. Its venous drainage is directly to the liver, and its lymphatic drainage is through Lund’s node. The gallbladder is innervated by both sympathetic and parasympathetic nerves. The common bile duct originates from the confluence of the cystic and common hepatic ducts and is located in the hepatobiliary triangle, which is bordered by the common hepatic duct, cystic duct, and the inferior edge of the liver. The cystic artery is also found within this triangle.

The correct answer is Cholecystokinin (CCK) as the woman is experiencing classic symptoms of biliary colic. CCK is released in response to fatty foods in the duodenum, causing increased gallbladder contraction and resulting in biliary colic.

Gastrin stimulates the secretion of gastric acid in response to stomach distension after a meal.

Prostaglandin causes uterine muscles to contract, leading to the expulsion of the uterine lining during menstruation. However, the patient’s symptoms are more indicative of biliary colic than dysmenorrhea.

Secretin decreases gastric acid secretion and increases pancreatic secretion, but it does not stimulate the gallbladder.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

Terlipressin works by constricting the splanchnic vessels, which increases systemic vascular resistance and promotes renal fluid reabsorption. This leads to an increase in arterial pressure and helps to treat hypovolaemic hypotension. Terlipressin also has a sympathetic stimulating effect and is an analogue of vasopressin.

Variceal haemorrhage is a serious condition that requires prompt and effective management. The initial treatment involves resuscitation of the patient, correction of clotting abnormalities, and administration of vasoactive agents such as terlipressin or octreotide. Prophylactic IV antibiotics are also recommended to reduce mortality in patients with liver cirrhosis. Endoscopic variceal band ligation is the preferred method for controlling bleeding, and the use of a Sengstaken-Blakemore tube or Transjugular Intrahepatic Portosystemic Shunt (TIPSS) may be necessary if bleeding cannot be controlled. However, TIPSS can lead to exacerbation of hepatic encephalopathy, which is a common complication.

To prevent variceal haemorrhage, prophylactic measures such as propranolol and endoscopic variceal band ligation (EVL) are recommended. Propranolol has been shown to reduce rebleeding and mortality compared to placebo. EVL is superior to endoscopic sclerotherapy and should be performed at two-weekly intervals until all varices have been eradicated. Proton pump inhibitor cover is given to prevent EVL-induced ulceration. NICE guidelines recommend offering endoscopic variceal band ligation for the primary prevention of bleeding for people with cirrhosis who have medium to large oesophageal varices.

To correctly diagnose this patient, knowledge of Courvoisier’s sign is necessary. This sign indicates that a palpable gallbladder in the presence of painless jaundice is unlikely to be caused by gallstones. Therefore, biliary colic is an incorrect answer as it is a painful condition. Haemolytic anaemia is also an incorrect answer as the blood test results would differ from this patient’s results. The correct answer is cholangiocarcinoma, which is a cancer of the biliary tree that can cause painless obstructive jaundice. Gilbert’s syndrome is not the most appropriate answer as it only presents with a raised bilirubin and does not cause an increase in ALP.

Understanding Cholangiocarcinoma

Cholangiocarcinoma, also known as bile duct cancer, is a serious medical condition that can be caused by primary sclerosing cholangitis. This disease is characterized by persistent biliary colic symptoms, which can be accompanied by anorexia, jaundice, and weight loss. In some cases, a palpable mass in the right upper quadrant may be present, which is known as the Courvoisier sign. Additionally, periumbilical lymphadenopathy (Sister Mary Joseph nodes) and left supraclavicular adenopathy (Virchow node) may be seen.

One of the main risk factors for cholangiocarcinoma is primary sclerosing cholangitis. This condition can cause inflammation and scarring of the bile ducts, which can lead to the development of cancer over time. To detect cholangiocarcinoma in patients with primary sclerosing cholangitis, doctors often use a blood test to measure CA 19-9 levels.

Smoking has been found to exacerbate Crohn’s disease, and it also increases the risk of disease recurrence after resection. Patients with ileal disease, which is the most common site of the disease, often exhibit fat wrapping of the terminal ileum. The mesenteric fat in patients with inflammatory bowel disease (IBD) is typically dense, hard, and prone to significant bleeding during surgery. During endoscopy, the mucosa in Crohn’s disease patients is described as resembling cobblestones, while ulcerative colitis patients often exhibit mucosal islands (pseudopolyps).

Understanding Crohn’s Disease

Crohn’s disease is a type of inflammatory bowel disease that can affect any part of the digestive tract, from the mouth to the anus. The exact cause of Crohn’s disease is unknown, but there is a strong genetic component. Inflammation occurs in all layers of the affected area, which can lead to complications such as strictures, fistulas, and adhesions.

Symptoms of Crohn’s disease typically appear in late adolescence or early adulthood and can include non-specific symptoms such as weight loss and lethargy, as well as more specific symptoms like diarrhea, abdominal pain, and perianal disease. Extra-intestinal features, such as arthritis, erythema nodosum, and osteoporosis, are also common in patients with Crohn’s disease.

To diagnose Crohn’s disease, doctors may look for raised inflammatory markers, increased faecal calprotectin, anemia, and low levels of vitamin B12 and vitamin D. It’s important to note that Crohn’s disease shares some features with ulcerative colitis, another type of inflammatory bowel disease, but there are also important differences between the two conditions. Understanding the symptoms and diagnostic criteria for Crohn’s disease can help patients and healthcare providers manage this chronic condition more effectively.

The most common type of colorectal cancer is adenocarcinoma, which originates from the mucosal lining of the colon. Initially, it develops as a benign adenoma from glandular cells of the mucosa, which later transforms into a malignant form.

Squamous cell carcinoma arises from squamous cells, which are not present in the colon. Ductal carcinoma is a breast cancer that originates from ductal cells. Basal cell carcinoma is a type of skin cancer, while mesothelioma is a malignancy that affects the mesothelium, commonly found in the lining of the chest wall.

Colorectal cancer is a prevalent type of cancer in the UK, ranking third in terms of frequency and second in terms of cancer-related deaths. Every year, approximately 150,000 new cases are diagnosed, and 50,000 people die from the disease. The cancer can occur in different parts of the colon, with the rectum being the most common location, accounting for 40% of cases. The sigmoid colon follows closely, with 30% of cases, while the descending colon has only 5%. The transverse colon has 10% of cases, and the ascending colon and caecum have 15%.

The presence of air in the gallbladder and biliary tree on an abdominal X-ray is most likely caused by a cholecystoenteric fistula. This is a serious complication of gallstones, particularly those larger than 2 cm, and can result in symptoms of small bowel obstruction such as severe abdominal pain, vomiting, and abdominal distension. While pneumoperitoneum may also be present in cases of cholecystoenteric fistula, it is not a specific finding and can be caused by other factors that weaken or tear hollow viscus organs. On the other hand, the presence of an appendicolith, a small calcified stone in the appendix, is highly indicative of appendicitis in patients with right iliac fossa pain and other associated symptoms, but is not seen in cases of cholecystoenteric fistula on an abdominal X-ray.

Gallstones are a common condition, with up to 24% of women and 12% of men affected. Local infection and cholecystitis may develop in up to 30% of cases, and 12% of patients undergoing surgery will have stones in the common bile duct. The majority of gallstones are of mixed composition, with pure cholesterol stones accounting for 20% of cases. Symptoms typically include colicky right upper quadrant pain that worsens after fatty meals. Diagnosis is usually made through abdominal ultrasound and liver function tests, with magnetic resonance cholangiography or intraoperative imaging used to confirm suspected bile duct stones. Treatment options include expectant management for asymptomatic gallstones, laparoscopic cholecystectomy for symptomatic gallstones, and surgical management for stones in the common bile duct. ERCP may be used to remove bile duct stones, but carries risks such as bleeding, duodenal perforation, cholangitis, and pancreatitis.

Pancreatic cancer is a type of cancer that is often diagnosed late due to its non-specific symptoms. The majority of pancreatic tumors are adenocarcinomas and are typically found in the head of the pancreas. Risk factors for pancreatic cancer include increasing age, smoking, diabetes, chronic pancreatitis, hereditary non-polyposis colorectal carcinoma, and mutations in the BRCA2 and KRAS genes.

Symptoms of pancreatic cancer can include painless jaundice, pale stools, dark urine, and pruritus. Courvoisier’s law states that a palpable gallbladder is unlikely to be due to gallstones in the presence of painless obstructive jaundice. However, patients often present with non-specific symptoms such as anorexia, weight loss, and epigastric pain. Loss of exocrine and endocrine function can also occur, leading to steatorrhea and diabetes mellitus. Atypical back pain and migratory thrombophlebitis (Trousseau sign) are also common.

Ultrasound has a sensitivity of around 60-90% for detecting pancreatic cancer, but high-resolution CT scanning is the preferred diagnostic tool. The ‘double duct’ sign, which is the simultaneous dilatation of the common bile and pancreatic ducts, may be seen on imaging.

Less than 20% of patients with pancreatic cancer are suitable for surgery at the time of diagnosis. A Whipple’s resection (pancreaticoduodenectomy) may be performed for resectable lesions in the head of the pancreas, but side-effects such as dumping syndrome and peptic ulcer disease can occur. Adjuvant chemotherapy is typically given following surgery, and ERCP with stenting may be used for palliation.

Gastric acid is released by parietal cells, while Brunner’s glands are located in the duodenum.

Understanding Gastric Secretions for Surgical Procedures

A basic understanding of gastric secretions is crucial for surgeons, especially when dealing with patients who have undergone acid-lowering procedures or are prescribed anti-secretory drugs. Gastric acid, produced by the parietal cells in the stomach, has a pH of around 2 and is maintained by the H+/K+ ATPase pump. Sodium and chloride ions are actively secreted from the parietal cell into the canaliculus, creating a negative potential across the membrane. Carbonic anhydrase forms carbonic acid, which dissociates, and the hydrogen ions formed by dissociation leave the cell via the H+/K+ antiporter pump. This leaves hydrogen and chloride ions in the canaliculus, which mix and are secreted into the lumen of the oxyntic gland.

There are three phases of gastric secretion: the cephalic phase, gastric phase, and intestinal phase. The cephalic phase is stimulated by the smell or taste of food and causes 30% of acid production. The gastric phase, which is caused by stomach distension, low H+, or peptides, causes 60% of acid production. The intestinal phase, which is caused by high acidity, distension, or hypertonic solutions in the duodenum, inhibits gastric acid secretion via enterogastrones and neural reflexes.

The regulation of gastric acid production involves various factors that increase or decrease production. Factors that increase production include vagal nerve stimulation, gastrin release, and histamine release. Factors that decrease production include somatostatin, cholecystokinin, and secretin. Understanding these factors and their associated pharmacology is essential for surgeons.

In summary, a working knowledge of gastric secretions is crucial for surgical procedures, especially when dealing with patients who have undergone acid-lowering procedures or are prescribed anti-secretory drugs. Understanding the phases of gastric secretion and the regulation of gastric acid production is essential for successful surgical outcomes.